Literature DB >> 7599255

Two-dimensional analysis of qualitative and quantitative changes in blood cell proteins in Alzheimer's disease: search for extraneuronal markers.

K M Mattila1, H Frey.   

Abstract

Numerous abnormalities have been reported to exist in tissues outside the central nervous system in Alzheimer's disease (AD), supporting the conception of the illness as a systemic disorder. Two-dimensional (2-D) polyacrylamide gel electrophoresis with an immobilized pH gradient of 4-8 in the first dimension combined with computer-assisted image analysis was applied in investigation of extraneuronal proteins of blood cell origin in AD to search for extraneuronal markers. No qualitative protein changes specific for the condition could be observed. However, many statistically significant quantitative alterations were detected when AD and control 2-D patterns of extracts prepared from red blood cell membranes, platelets and lymphocytes were compared. One of these spots, with a marked change in mean intensity value, was identified as actin. The concentration of this protein was significantly reduced in AD platelets and lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599255

Source DB:  PubMed          Journal:  Appl Theor Electrophor        ISSN: 0954-6642


  5 in total

1.  Problems associated with biological markers of Alzheimer's disease.

Authors:  H J Frey; K M Mattila; M A Korolainen; T Pirttilä
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 2.  Two-dimensional protein electrophoresis: from molecular pathway discovery to biomarker discovery in neurological disorders.

Authors:  Leila H Choe; Brenda G Werner; Kelvin H Lee
Journal:  NeuroRx       Date:  2006-07

3.  Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?

Authors:  Michelle M Mielke; Norman J Haughey
Journal:  Clin Lipidol       Date:  2012-10

4.  Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: a pilot-study.

Authors:  Josef Marksteiner; Douglas Imarhiagbe; Michaela Defrancesco; Eberhard A Deisenhammer; Georg Kemmler; Christian Humpel
Journal:  Exp Gerontol       Date:  2013-12-10       Impact factor: 4.032

5.  Plasma biomarkers of brain atrophy in Alzheimer's disease.

Authors:  Madhav Thambisetty; Andrew Simmons; Abdul Hye; James Campbell; Eric Westman; Yi Zhang; Lars-Olof Wahlund; Anna Kinsey; Mirsada Causevic; Richard Killick; Iwona Kloszewska; Patrizia Mecocci; Hilkka Soininen; Magda Tsolaki; Bruno Vellas; Christian Spenger; Simon Lovestone
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.